BIO Digital | 8 – 12 June 2020

For 2020, the BIO International Convention will transition to a new, virtual event format, BIO Digital. This virtual gathering of the global biotech industry provides access to key partners via BIO One-on-One Partnering, educational resources to help drive your business, and the insights you need to continue critical research and development.

We may not be able to gather in person, but nothing stops innovation.

Cora Griffin, Orbit’s BD Manager will be available digitally for partnering meetings.


BIO-EUROPE Spring, DELIVERED DIGITALLY | 23 – 27 March 2020

A situation out of our control is preventing us from doing business in a face-to-face environment, so we’ve come together to offer an alternative solution. We will now be delivering BIO-Europe Spring as a fully digital event, offering virtual partnering, online company presentations, pre-recorded panels and a virtual exhibit. The digital event will take place March 23–27, 2020.

Alex Batchelor, Orbit’s CEO will be available digitally for partnering meetings.


LSX World Congress, London | 4 – 5 February 2020

LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life science giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

The industry’s c-suite will be joined by the sector’s most active investors, pharma and health-tech BD&L teams, key stakeholders and top tier service companies who are moving the sector forward..

Cora Griffin, Orbit’s BD Manager will be available in London for partnering meetings.


Biotech Showcase, San Francisco | 13 – 15 January 2020

The investor conference that drives the future of drug development.

With more than $400 billion in capital represented, Biotech Showcase, January 13–15, 2020, is one of the industry’s leading investor conferences expecting more than 3,700 attendees, 2,200 companies, and over 1,000 investors.

Alex Batchelor, CEO of Orbit Discovery will be available in San Francisco for partnering meetings.


Synthetic Biology UK, Warwick | 9 – 10 December 2019

Synthetic biology is a convergence of multiple fields that can generate both improved understanding of biological systems as well as cutting-edge biotechnology.

Synthetic Biology UK 2019 will explore the unique opportunities of research in a number of areas of synthetic biology, establishing likely future directions and facilitating discussion about appropriate strategies. It will provide an excellent framework for younger scientists and engineers to learn about burgeoning new areas of activity, including the engineering of microbial communities and of microbial-plant interactions.

For Orbit Discovery Christel Compper will attend.


OBN BioLearn, Oxford | 19 November 2019

This course represents an excellent opportunity for staff who are new to the drug discovery industry, those in non-scientific roles or beginning careers as a scientist to gain or develop an in-depth knowledge of the sector.

During this half-day course the structure and commercial environment of the biopharmaceutical industry including key technical aspects of the drug development process will be covered.

For Orbit Discovery we will have Simon Bushell, Maryana Baran, Giulia Poloni, Juan Bolivar Gonzalez and Giovanna Cacciola attend.


PEGS Europe, Lisbon | 18 – 22 November 2019

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2018, more than 1,100 delegates from 36 countries, including 70% from pharma and biotech organizations, convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering.

For Orbit Discovery, Li Phing Liew will attend this conference.


BIO-Europe, Hamburg | 11 – 13 November 2019

As Europe’s largest life science partnering conference, BIO-Europe offers countless opportunities to engage with global life science partners. Empower yourself with knowledge from key biotech and pharma leaders who will discuss the latest industry trends in workshops and panels.

For Orbit Discovery, Cora Griffin and Alex Batchelor will be available for partnering meetings.


8th Annual Cell Culture & Bioprocessing Congress, London | 29 – 30 October 2019

Over 450 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture, bioprocessing technologies and cell banking.

Featuring the following key themes:

• Cell Line Development & Engineering
• Genomic Approaches to Cell Line Development
• 3D Cell Culture Models & Applications
• Upstream Bioprocessing & Analytics
• Downstream Bioprocessing

Alongside the main programme, new for 2019 the event will include a featured session on Cell Banking on Day 1.

For Orbit Discovery Seunghee Kang, Lydia Aschauer, Sarah Collins and Michelle Adsett will attend this conference.


ELRIG Drug Discovery, Liverpool | 5 – 6 November 2019

Drug Discovery 2019 – Looking Back To The Future

Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at ACC in Liverpool.

This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery.

Our scientific programme will feature over 40 world-class speakers with 6 main session tracks. In partnership with key academic and charitable groups, we will also run joint disease and biology-oriented tracks focusing on the basic sciences that underpin successful drug discovery.

For Orbit Discovery, Kathleen Humphreys, Christel Compper and Madeleine Smee will attend this conference.

Close Menu